Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2019 Oct 30;18(5):1161–1169.e5. doi: 10.1016/j.cgh.2019.10.036

Figure 3.

Figure 3.

SNP-stratified tumor marker levels in patients with localized pancreatic ductal adenocarcinoma: All PDAC cases (top panel), Stage I cases only (bottom panel). CA19-9 levels differed within SNP subgroups (FUT2−/− versus other groups and FUT3−/− versus other groups, p<0.00001, Mann-Whitney).